May 12, 2020 / 05:40PM GMT
Derik De Bruin - BofA Merrill Lynch, Research Division - MD of Equity Research
Hello. Good afternoon, everyone. This is Derik De Bruin, the Bank of America life sciences and diagnostic tools analyst. Welcome to our 2020 Healthcare Conference, Virtual Vegas. I thought about sending around some scratch and sniff cards, so you could get a sense of the cheap perfume and cigarettes, but they didn't have that in the budget.
So to kick off our next session, it's our pleasure to have Avantor. With us today from Avantor is Mike Stubblefield, President and CEO; and Tom Szlosek, Executive Vice President and CFO. Gentlemen, welcome to Virtual Vegas. Thanks for being here today.
Michael Stubblefield - Avantor, Inc. - President, CEO & Director
Yes, thanks, Derik. Happy to be with you as well. Thanks for hosting this.
Questions and Answers:
Derik De Bruin - BofA Merrill Lynch, Research Division - MD of Equity ResearchGreat. So it's been -- I mean it's hard to believe, but it's been a year since Avantor's IPO. I
Trustpilot
